Petra Jelenc

Petra Jelenc is a financial analyst currently employed at Swixx BioPharma since January 2022, bringing extensive experience from Sanofi where roles spanned over a decade, including Financial Planning and Analysis Expert across 14 countries and Financial Planning Analyst for 9 countries. Expertise includes comprehensive internal reporting, budgeting, and planning aligned with corporate guidelines, alongside financial tool management and cross-functional collaboration. Notable achievements include participation in the implementation of the TM1 planning and forecasting tool. Petra holds a Bachelor of Science in Accounting and Finance from Ekonomska fakulteta v Ljubljani and completed pre-university education at Ekonomska Gimnazija v Ljubljani.